John G. Freund - Jun 8, 2023 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
Director
Signature
/s/ Edward C. Albini as attorney-in-fact
Stock symbol
STRO
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4
Date filed
6/12/2023, 06:32 PM
Previous filing
May 19, 2023
Next filing
Jun 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Stock Option (right to buy) Award $0 +25K $0.00 25K Jun 8, 2023 Common Stock 25K $5.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 8.33% of the total shares monthly, commencing July 8, 2023, with 100% of the total shares vested and exercisable on the earlier of the issuer's 2024 annual stockholders meeting or June 8, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.